Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan

Xiaoyan WANG; Ya LI; Chenglu HE; Lin WANG; Zhiqiang MA; Xinrui WAN

doi:10.12259/j.issn.2095-610X.S20231209

Volume 44 Issue 12

Dec. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(12): 51-58

Xiaoyan WANG, Ya LI, Chenglu HE, Lin WANG, Zhiqiang MA, Xinrui WAN. Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan[J]. Journal of Kunming Medical University, 2023, 44(12): 51-58. doi: 10.12259/j.issn.2095-610X.S20231209

Citation:

Xiaoyan WANG, Ya LI, Chenglu HE, Lin WANG, Zhiqiang MA, Xinrui WAN. Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan[J]. Journal of Kunming Medical University, 2023, 44(12): 51-58. doi: 10.12259/j.issn.2095-610X.S20231209

Citation:

Xiaoyan WANG, Ya LI, Chenglu HE, Lin WANG, Zhiqiang MA, Xinrui WAN. Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan[J]. Journal of Kunming Medical University, 2023, 44(12): 51-58. doi: 10.12259/j.issn.2095-610X.S20231209

PDF( 1222 KB)

Study on Immune Function and Drug Resistance of Tuberculosis Patients Co-infected with HBV，HCV and HIV in Yunnan

doi: 10.12259/j.issn.2095-610X.S20231209

Xiaoyan WANG^{1, 2},
Ya LI^{1
,
,},
Chenglu HE^{1
,
,},
Lin WANG²,
Zhiqiang MA²,
Xinrui WAN²

1.
Dept. of Medical Laboratory，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032
2.
Dept. of Laboratory，The 3rd People’s Hospital of Kunming，Kunming Yunnan 650301，China

Received Date: 2023-09-24
Available Online: 2023-12-20
Publish Date: 2023-12-25

Abstract

Abstract

Objective To explore the co-infection rate, immune function and drug resistance status among tuberculosis patients co-infected with HBV, HCV and HIV in Yunnan. Methods A total of 2271 TB patients in Yunnan province admitted to the Third People's Hospital of Kunming from April 2020 to March 2023 were collected for HBV, HCV, HIV serological tests, lymphocyte tests and drug resistance gene detection, and analysis of TB infection of HBV, HCV, HIV infection, immune function and resistance. Results Among the 2271 TB patients, 499 cases were infected with TB and HBV, the infection rate was 21.97%. 196 cases were infected with HCV, the infection rate was 8.63%. 166 cases were infected with HIV, the infection rate was 7.31%. There were 1410 patients with simple tuberculosis, accounting for 62.09%. The infection rates of tuberculosis combined with HBV, HCV and HIV were statistically significant in different age groups（P < 0.01）. The absolute number expression of CD3⁺, CD4⁺ and CD8⁺T cells was higher in TB patients with HBV and HCV, and the differences between the two were statistically significant（P < 0.05）.The absolute number expression of CD3⁺ and CD4⁺T cells was lower in TB patients with HIV, and the absolute number expression of CD8⁺T cells was increased, and the difference between the two was statistically significant（P < 0.01）. The absolute number of CD3⁺, CD4⁺ and CD8⁺T cells was higher in female patients with tuberculosis and HIV, and the differences were statistically significant（P < 0.05）. In all age groups, the absolute number of CD3⁺ and CD8⁺T cells in tuberculosis patients with HIV was the lowest in 46-65 years old group, and the differences were statistically significant（P < 0.05）. Among the 2271 TB patients, 391 were resistant to any first-line drug（single drug resistance）, and the overall drug resistance rate was 17.22%. Among them, 52 cases were combined with HBV drug resistance, the resistance rate was 10.42%. There were 10 cases with HCV drug resistance, the drug resistance rate was 5.10%. 40 cases were combined with HIV drug resistance, the drug resistance rate was 24.10%. Drug resistance in 289 patients with simple tuberculosis was 20.50%. Among them, 33 cases were single drug resistant rifampicin, accounting for 19.88%. Conclusion Tuberculosis has the highest rate of co-infection with HBV, and the immune function of TB patients co-infected with HIV is the worst. The drug resistance rate of TB patients co-infected with HIV is also the highest, with resistance to rifampicin being the most common. TB is a chronic wasting disease, with poorer immune function compared to the general population, making it more susceptible to HBV infection. TB patients who are also infected with HIV tend to have worsened immune function and increased drug resistance.
- Tuberculosis,
- Hepatitis B virus,
- Hepatitis C virus,
- Human immunodeficiency virus,
- Drug resistance,
- Yunnan region

FullText(HTML)

References(19)

References

[1]	Massimo D P,Maria T M,Luisa Bi,et al. Evaluation of LIAISON^®XL System for HBs Ag,and anti-HCV and anti-HIV/Ag p24[J]. Journal of Medical Virology,2017,89(8):489-496.
[2]	秦志华,顾尔莉,施军卫,等. 抗结核治疗导致乙型肝炎病毒再激活相关性研究[J]. 中国热带医学,2022,22(2):138-142.
[3]	马世武,王嘉睿,朱娅梅. 结核合并丙型肝炎病毒感染同时治疗的药物选择[J]. 中华肝脏病杂志,2022,30(1):113-116.
[4]	卢春容,房宏霞,陆普选,等. WHO 2021年全球结核病报告: 全球与中国关键数据分析[J]. 新发传染病电子杂志,2021,6(4):368-372.
[5]	肺结核诊断 WS 288—2017[J]. 中国感染控制杂志, 2018, 17（7）: 642-652.
[6]	周颖. 结核分枝杆菌异烟肼耐药性与脂肪酸合成代谢基因accD1和mcr相关性的初步研究[D]. 长春: 吉林农业大学, 2020.
[7]	王钰婷,陶必林,李忠奇,等. 全球结核分枝杆菌谱系分布与耐药分析[J]. 中华疾病控制杂志,2022,26(11):1248-1251,1295.
[8]	Chakaya J,Khan M,Ntoumi F,et al. Global tuberculosis report 2020-reflections on the Global TB burden,treatment and prevention efforts[J]. International Journal of Infectious Diseases,2021,113 Suppl 1(Suppl 1):S7-S12.
[9]	梁思敏. 新疆南疆地区抗结核药物性肝损伤危险因素分析及列线图预测模型的构建[D]. 乌鲁木齐: 新疆医科大学, 2023.
[10]	叶洁桐. 化瘀柔肝方联合恩替卡韦治疗乙肝肝硬化的临床观察[J]. 中国中医药科技,2022,29(6):1028-1030.
[11]	晁春梅,哏传香,金正英,等. 2015-2019年云南省献血者血清阳性隐匿性乙肝病毒感染流行病学特征[J]. 热带医学杂志,2021,21(5):650-652+669.
[12]	李涛, 闫翔宇, 杜昕, 等. 中国肺外结核流行现状的全国性调查研究[C]. 中国防痨协会, 2023, 2（1）: 198-199.
[13]	王新霞,吴晓美,童涌. 艾滋病患者结核杆菌感染与其免疫功能及HIV载量的关系[J]. 中国现代医生,2022,60(6):8-11+50.
[14]	张凌,陈玉萍,李琴. HIV感染者HBV HCV TP及TB检测结果研究[J]. 基层医学论坛,2021,25(26):3792-3794.
[15]	唐柳生, 黄于萍, 雷振, 等. 223株艾滋病合并感染结核分枝杆菌临床分离株的耐药特征[C]. 中国防痨协会, 2023, 2（1）: 363-365.
[16]	王娟娟,施旭东,肖园园,等. 南京地区HIV/AIDS患者分枝杆菌感染分布及耐药性分析[J]. 临床检验杂志,2021,39(2):148-150.
[17]	王印,朱迎春,周锐峰,等. HIV/AIDS合并结核病患者196株结核分枝杆菌耐药分析[J]. 重庆医学,2017,46(9):1203-1205.
[18]	古丽米拉·达列力汗,宋玉霞,李弘,等. 艾滋病合并结核病患者结核分枝杆菌耐药分析[J]. 传染病信息,2022,35(3):245-247,258.
[19]	律彤. 云南省利福平耐药肺结核患者经济负担现状及影响因素研究[D]. 昆明: 昆明医科大学, 2022.

Relative Articles(20)

Relative Articles

[1]	Yanzhu YIN, Zushun YANG, Yanqiushuo ZOU, Xiang REN, Yidan GUO, Lu FAN. Investigation of Molecular Typing and Drug Resistance of Shigella in Yunnan Province from 2016 to 2022. Journal of Kunming Medical University, 2024, 45(7): 79-86. doi: 10.12259/j.issn.2095-610X.S20240712
[2]	Yihan LIU, Jun LIU, Yongmei JIN, Bo TIAN, Jinsong BAI. Risk Assessment and Analysis of Risk Factors for Cardiovascular Disease in HIV Antiviral Therapy Patients. Journal of Kunming Medical University, 2024, 45(10): 140-146. doi: 10.12259/j.issn.2095-610X.S20241022
[3]	Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy. Journal of Kunming Medical University, 2024, 45(9): 163-167. doi: 10.12259/j.issn.2095-610X.S20240925
[4]	Yunshan LIAO, Shuangshuang WANG, Lijuan YIN, Yuting ZHENG. Mental Health Status of Emergency Rescue Nurses in Yunnan Province. Journal of Kunming Medical University, 2023, 44(8): 177-184. doi: 10.12259/j.issn.2095-610X.S20230824
[5]	Lianyong CHEN, Xing YANG, Haohao RU, Tao CHEN, Shuangqun YAN, Lin XU. Analysis of Molecular Characteristics of Mycobacterium Tuberculosis and Factors Associated with Transmission in Yunnan Province. Journal of Kunming Medical University, 2023, 44(8): 1-7. doi: 10.12259/j.issn.2095-610X.S20230821
[6]	Jie LI, Yuan HE, Chunyan WU, Bin SHAN, Rui ZHENG, Zhifu GUAN, Baojun REN, Chunxia SHI, Youquan ZHOU, Hanyu LIU, Mi ZHANG, Yanming KANG, Guibo SONG. Distribution and Drug Resistance Analysis of Bacteria in Sterile Body Fluids in Yunnan from 2017 to 2021. Journal of Kunming Medical University, 2023, 44(3): 61-67. doi: 10.12259/j.issn.2095-610X.S20230309
[7]	Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy. Journal of Kunming Medical University, 2023, 44(5): 162-167. doi: 10.12259/j.issn.2095-610X.S20230508
[8]	Lin WANG, Lingjun SHEN, Haiwen LI, Xiaoyan WANG, Jianpeng GAO, Zhiqiang MA. Analysis of Nutritional Status and Immune Function of Tuberculosis Patients in Yunnan. Journal of Kunming Medical University, 2023, 44(1): 109-115. doi: 10.12259/j.issn.2095-610X.S20230116
[9]	Xinrui WAN, Xiaoyan WANG, Lin WANG, Zhiqiang MA, Caixin LI, Shitao XU, Xingrui TANG, Hongyan Mao. Liver，Kidney and Immunologic Function and Drug Resistance in Patients with Nontuberculous Mycobacteria Infection. Journal of Kunming Medical University, 2023, 44(11): 113-119. doi: 10.12259/j.issn.2095-610X.S20231117
[10]	Dong PU, Tingting YU, Lihua LI, Runwu ZHANG, Kunli WU, Dongling LI. Analysis of Serum High-sensitivity HBV DNA in Patients with Chronic Hepatitis B with Low Viral Load in Kunming Area. Journal of Kunming Medical University, 2023, 44(1): 116-121. doi: 10.12259/j.issn.2095-610X.S20230114
[11]	Lin WANG, Yingrong DU, Jianpeng GAO, Mingwu LI, Lingjun SHEN, Zhiqiang MA. Nutritional Status of Elderly Tuberculosis Patients in Yunnan. Journal of Kunming Medical University, 2022, 43(4): 32-37. doi: 10.12259/j.issn.2095-610X.S20220432
[12]	Xiaojie CHEN, Xingrao WU, Shuhui YU, Zheng LI, Lan ZHANG. Advances on HBV Infection in the Occurrence and Development of Gynecologic Malignancies. Journal of Kunming Medical University, 2022, 43(4): 152-157. doi: 10.12259/j.issn.2095-610X.S20220424
[13]	Fan CAO, Yang-wen LIU, Lei WEI, Nan XIE, Yi-jian YANG, Cheng QIAN, Chun-mang LI, Bi-mang FU, Jiang-pin XU, Rong-ji YAN, Wang ZENG. Correlation between Hepatitis B Virus and Microvascular Invasion in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2021, 42(3): 127-134. doi: 10.12259/j.issn.2095-610X.S20210331
[14]	Chen Lian Yong , Ru Hao Hao , Yang Xing , Yan Shuang Qun , Chen Jin Ou , Yang Rui , Chen Tao , Xu Lin . . Journal of Kunming Medical University, 2020, 41(03): 45-49.
[15]	Pu Dong , Li Xiao Fei , Yu Ting Ting , Wang Hong Ying , Zhang Run Wu , Li Li Hua , Bai Jing , Ding Cai Mei , Li Dong Ling , Yang Yong Rui . . Journal of Kunming Medical University, 2020, 41(06): 149-155.
[16]	Pu Dong , Yu Ting Ting , Wang Hong Ying , Li Li Hua , Zhang Run Wu , Ding Cai Mei , Bai Jing , Li Dong Ling , Li Xiao Fei . . Journal of Kunming Medical University, 2019, 40(11): 131-135.
[17]	Ding Jia Wei , Xu Yi Heng , Li Jing Yu , Gao Ling , Wu Han Xin , Wen Yan Ping , Li Meng Xian , Tai Wen Lin . An Analysis of the Status of General Population with HCV Infection in Kunming Region from 2013 to 2015. Journal of Kunming Medical University, 2018, 39(02): 88-93.
[18]	Shi Xin Huan , Tang Rui Zhu , Liu Zi Jie , Lu Yan Zhou , Li Huan . The Changes of Hepatitis C Virus Gene Subtypes and RNA Loads in the Development of Chronic Hepatitis C Patients in Yunnan. Journal of Kunming Medical University, 2018, 39(06): 57-61.
[19]	Li Yong Gang . Vertical Transmission of Hepatitis B Virus in Human Early Embryos. Journal of Kunming Medical University,
[20]	Gao Xiao Jiao . . Journal of Kunming Medical University,